Dapagliflozin Reduced LVMI in Patients with CKD : DECODE-CKD
Key Points The DECODE-CKD trial investigated the effects of SGLT-2 inhibitor Dapagliflozin on cardiac structure and function in patients with chronic kidney disease... Read more.
Benefit from Intensive BP Control Across Frailty Statuses – A Post-Hoc Analysis of ESPRIT trial
Key Points The ESPRIT trial assessed whether the efficacy and safety of intensive blood pressure (BP) varies across frailty status compared to control. In this open-label... Read more.